review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | R Pujol-Borrell | Q38642581 |
P2093 | author name string | Todd I | |
Belfiore A | |||
Bottazzo GF | |||
Mirakian R | |||
P2860 | cites work | Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies | Q28237011 |
Autoimmune thyroid disease | Q28282452 | ||
Serology of Bacterionema matruchotii | Q33190692 | ||
Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value | Q34068275 | ||
Parathyroid cell surface autoantibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells | Q34174660 | ||
Autoantibodies to Insulin Receptors in Man: Immunological Determinants and Mechanism of Action | Q34249612 | ||
A cell-surface molecule involved in organ-specific homing of lymphocytes | Q34272163 | ||
Autoantibodies to gut hormone secreting cells as markers of peptide deficiency | Q34495901 | ||
Autoantibodies against human insulin | Q34555621 | ||
Human multiple organ-reactive monoclonal autoantibody recognizes growth hormone and a 35,000-molecular weight protein | Q34618347 | ||
Characterization of antibodies to the insulin receptor: a cause of insulin-resistant diabetes in man | Q35905356 | ||
Ultrastructure of intermediate stages in polarity reversal of thyroid epithelium in follicles in suspension culture | Q36201701 | ||
Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis | Q36299093 | ||
The thyroid "microsomal" antibody revisited. Its paradoxical binding in vivo to the apical surface of the follicular epithelium | Q36348505 | ||
Murine gamma interferon activates the release of a macrophage-derived Ia-inducing factor that transfers Ia inductive capacity | Q36348745 | ||
Possible role for a human adenovirus in the pathogenesis of celiac disease | Q36349555 | ||
Persistent expression of Ia antigen and viral genome in visna-maedi virus-induced inflammatory cells. Possible role of lentivirus-induced interferon | Q36351427 | ||
Monoclonal human thyroid cell line GEJ expressing human thyrotropin receptors | Q37683422 | ||
Autoantibodies to vasopressin cells in idiopathic diabetes insipidus: evidence for an autoimmune variant | Q72549288 | ||
Autoantibodies are anti-idiotype antibodies to antiviral antibodies | Q72562485 | ||
Methimazole and insulin autoimmune syndrome with hypoglycemia | Q72565011 | ||
Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity | Q72565145 | ||
Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity | Q72565150 | ||
Methimazole and insulin autoimmune syndrome | Q72567638 | ||
Antibodies to melanocytes in vitiligo | Q72569639 | ||
Pathogenesis of insulin-dependent diabetes: a role for activated T lymphocytes | Q72582627 | ||
Expression of HLA-DR in hair follicles in alopecia areata | Q72584821 | ||
Presence of the organ-specific 'microsomal' autoantigen on the surface of human thyroid cells in culture: its involvement in complement-mediated cytotoxicity | Q72653940 | ||
Studies on thyroid cell surface antigens using cultured human thyroid cells | Q72664869 | ||
Essential requirement for major histocompatibility complex recognition in T-cell tolerance induction | Q72726082 | ||
Asialoagalactothyroglobulin binds to the surface of human thyroid cells at a site distinct from the 'microsomal' autoantigen | Q72730009 | ||
Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis | Q72748709 | ||
Evidence for Cell-Mediated Immunity and Specific Suppressor T Lymphocyte Dysfunction in Graves’ Disease and Diabetes Mellitus* | Q72792481 | ||
Antigen presentation: comments on its regulation and mechanism | Q72802483 | ||
Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre | Q72829872 | ||
Familial Neonatal Transient Hypothyroidism Due to Maternal TSH-Binding Inhibitor Immunoglobulins | Q72859927 | ||
Autonomic abnormalities and autoantibodies to beta-adrenergic receptors | Q72909798 | ||
Auto-antibodies in Hashimoto's disease (lymphadenoid goitre) | Q74260558 | ||
THE CYTOPLASMIC AUTO-ANTIGEN OF THE HUMAN THYROID. I. IMMUNOLOGICAL AND BIOCHEMICAL CHARACTERISTICS | Q76914041 | ||
The presence of an abnormal thyroid-stimulating hormone in the serum of some thyrotoxic patients | Q77217120 | ||
Hypotheses on genetic contributions to the aetiology of diabetes mellitus | Q85699332 | ||
Thyrotrophin stimulation of mitogenesis of the rat thyroid cell strain FRTL-5: a metaphase index assay for the detection of thyroid growth stimulators | Q93609047 | ||
The incidence of parathyroid and other antibodies in the sera of patients with idiopathic hypoparathyroidism | Q39107648 | ||
Detection and Properties of TSH-Binding Inhibitor Immunoglobulins in Patients with Graves’ Disease and Hashimoto’s Thyroiditis* | Q39309509 | ||
Islet-cell antibodies in juvenile diabetes mellitus of recent onset | Q39321628 | ||
Autoantibodies to prolactin-secreting cells of human pituitary | Q39334066 | ||
Separate autoantibodies to human pancreatic glucagon and somatostatin cells | Q39404921 | ||
Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus | Q39479098 | ||
Autoantibodies to parathyroid hormone receptor | Q39520614 | ||
A human-specific mitochondrial antibody its importance in the identification of organ-specific reactions | Q40796957 | ||
Islet-Cell-Surface Antibodies in Juvenile Diabetes Mellitus | Q40913898 | ||
Autoantibodies to Gastrin-Producing Cells in Antral (Type B) Chronic Gastritis | Q41039408 | ||
Insulin autoantibodies in the pre-diabetic period: correlation with islet cell antibodies and development of diabetes | Q41353735 | ||
Antithyrotropin antibodies in the sera of Graves' disease patients | Q41361597 | ||
Insulin as a surface marker on isolated cells from rat pancreatic islets | Q41419307 | ||
Antigen specific suppressor cell function in autoimmune chronic active hepatitis | Q41544516 | ||
Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells | Q41561517 | ||
Surface-reactive antibodies to human adrenal cells in Addison's disease. | Q41616975 | ||
Demonstration of an epithelial antigen in colon by means of fluorescent antibodies from children with ulcerative colitis | Q42202909 | ||
Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase | Q42449804 | ||
Family Studies of Hypergastrinemic, Hyperpepsinogenemic I Duodenal Ulcer | Q42471447 | ||
Coexisting thyroid and gastric autoimmune diseases are not due to cross-reactive autoantibodies | Q42665081 | ||
Detection of HLA-DR antigens in paraffin-embedded thyroid epithelial cells with a monoclonal antibody | Q42752943 | ||
Antibodies to normal human melanocytes in vitiligo | Q42936596 | ||
Aberrant expression of HLA-DR antigens by insulin-containing beta-cells in recent-onset type I diabetes mellitus | Q43488548 | ||
Syngeneic sensitization of mouse lymphocytes on monolayers of thyroid epithelial cells. VII. Generation of thyroid-specific cytotoxic effector cells | Q43633673 | ||
Viral particles induce Ia antigen expression on astrocytes | Q48355274 | ||
Lawrence lecture. Death of a beta cell: homicide or suicide? | Q48533871 | ||
Human monoclonal autoantibodies that react with multiple endocrine organs | Q48773222 | ||
Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset | Q49173574 | ||
Development of the gonadotrophic resistant ovary syndrome in myasthenia gravis: suggestion of similar autoimmune mechanisms | Q53854081 | ||
Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial. | Q53885179 | ||
Inhibition of parietal cell function by human gammaglobulin containing gastric parietal cell antibodies. | Q53959487 | ||
Epithelial HLA-DR expression and T lymphocyte subsets in salivary glands in Sjögren's syndrome | Q57352810 | ||
Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins | Q57449719 | ||
Autoantibodies to the insulin receptor in juvenile onset insulin-dependent diabetes | Q59051564 | ||
Thyroid growth-blocking antibodies in primary myxoedema | Q59061454 | ||
Lectin-induced expression of DR antigen on human cultured follicular thyroid cells | Q59084396 | ||
Autoimmune human T lymphocytes specific for acetylcholine receptor | Q59092674 | ||
Gastric parietal cell antibodies: demonstration by immunofluorescence of their reactivity with surface of the gastric parietal cells | Q67243008 | ||
In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis | Q67296143 | ||
Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid diseases: relationship with lymphocytic infiltration and thyroid autoantibodies | Q68125388 | ||
Cytolytic T lymphocytes with natural killer activity in thyroid infiltrate of patients with Hashimoto's thyroiditis: analysis at clonal level | Q68792283 | ||
Antiinsulin receptor antibodies in an insulin-dependent diabetic may arise as autoantiidiotypes | Q68798741 | ||
Autoimmunity to insulin, beta cell dysfunction, and development of insulin-dependent diabetes mellitus | Q68858707 | ||
Familial Cushing's syndrome due to nodular adrenocortical dysplasia. A putative receptor-antibody disease? | Q69509980 | ||
Role of maternal immunoglobulins blocking TSH-induced thyroid growth in sporadic forms of congenital hypothyroidism | Q69856509 | ||
Value of insulin autoantibodies as serum markers for insulin-dependent diabetes mellitus | Q69857646 | ||
Further studies on thyroid growth-stimulating immunoglobulins in euthyroid nonendemic goiter | Q69859021 | ||
Effects of platelet-derived growth factor and epidermal growth factor on antigen-induced proliferation of human T-cell lines | Q69865223 | ||
Human T-cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells | Q69865739 | ||
In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis | Q69882047 | ||
Identification of a thyroid microsomal antigen by Western blot and immunoprecipitation | Q69892787 | ||
Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases | Q69901089 | ||
Demonstration and characterization of anti-human mitochondria autoantibodies in idiopathic hypoparathyroidism and in other conditions | Q69925178 | ||
Interferon-gamma induces HLA-DR expression by thyroid epithelium | Q69963904 | ||
"Cytoplasmic" islet cell antibodies. Evidence that the target antigen is a sialoglycoconjugate | Q70089965 | ||
Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases | Q70100845 | ||
Anti-thyroid peroxidase antibody in patients with autoimmune thyroid disease: possible identity with anti-microsomal antibody | Q70101555 | ||
Direct and quantitative measurement by immunoprecipitation assay of anti-thyrotrophin receptor antibodies in sera of patients with Graves' disease | Q70201047 | ||
Islet cell surface antibodies in type 1 (insulin-dependent) diabetes mellitus: use of human fetal pancreas cultures as substrate | Q70218976 | ||
Lymphocytes capable of making monoclonal autoantibodies that react with multiple organs are a common feature of the normal B cell repertoire | Q70226850 | ||
Autoantibodies to insulin receptor spontaneously develop as anti-idiotypes in mice immunized with insulin | Q70227993 | ||
Parietal cell surface reactive autoantibody in pernicious anaemia demonstrated by indirect membrane immunofluorescence | Q70262141 | ||
Insulin Antibodies in Insulin-Dependent Diabetics Before Insulin Treatment | Q70311233 | ||
Differential expression and regulation of MHC products in the endocrine and exocrine cells of the human pancreas | Q70315600 | ||
Mouse antibodies to the insulin receptor developing spontaneously as anti-idiotypes. I. Characterization of the antibodies | Q70355167 | ||
?-Cell damage in diabetic insulitis: are we approaching a solution? | Q70362181 | ||
In vitro and in vivo reversal of thyroid epithelial polarity: its relevance for autoimmune thyroid disease | Q70373474 | ||
Twin-to-twin pancreas transplantation: reversal and reenactment of the pathogenesis of type I diabetes | Q70419845 | ||
Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease | Q70914265 | ||
Epidermal growth factor modulates thyroid growth and function in culture | Q70983744 | ||
Flow microfluorimetric analysis of autoantibody reactions with parietal cell surface membranes in pernicious anaemia | Q71140612 | ||
Detection of thyroid growth immunoglobulins (TGI) by [3H]-thymidine incorporation in cultured rat thyroid follicles | Q71247373 | ||
Effects of antithyroid drugs on lymphocyte proliferative responses to lectins: relationship between insulin autoimmune syndrome and methimazole | Q71248661 | ||
Role of a secretagogue immunoglobulin in gastric acid secretion | Q71487277 | ||
Syngeneic sensitization of mouse lymphocytes on monolayers of thyroid epithelial cells. III. Induction of thyroiditis by thyroid-sensitized T lymphoblasts | Q72110667 | ||
Correlation of the HLA-A1,B8 haplotypes with circulating autoantibodies in a family with increased incidence of autoimmune disease | Q72113604 | ||
Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage | Q72422543 | ||
Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation | Q72500485 | ||
P304 | page(s) | 137-169 | |
P577 | publication date | 1986-12-01 | |
P1433 | published in | Immunological Reviews | Q15724582 |
P1476 | title | Organ-specific autoimmunity: a 1986 overview | |
P478 | volume | 94 |
Q64117188 | "Balancing" balancing selection? Assortative mating at the major histocompatibility complex despite molecular signatures of balancing selection |
Q24554232 | A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y |
Q71541316 | An immunohistochemical study of immunological phenomena in minor salivary glands in patients with Sjögren's syndrome |
Q43187569 | Analysis of RNA transcripts for HLA class II genes in human small intestinal biopsies |
Q56902305 | Analysis of the human HLA-DRA gene upstream region: evidence for a stem-loop array directed by nuclear factors |
Q39334546 | Anti-calreticulin antibodies and calreticulin in sera of patients diagnosed with dilated or hypertrophic cardiomyopathy. |
Q33578829 | Anti-endothelial cell antibodies: detection and characterization in sera from patients with autoimmune hypoparathyroidism |
Q37896220 | Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity |
Q36635307 | Antigen Recognition and Peptide-Mediated Immunotherapy in Autoimmune Disease |
Q68358537 | Antigen presentation by keratinocytes induces tolerance in human T cells |
Q59081576 | Antigen presenting function of class II MHC expressing pancreatic beta cells |
Q77308459 | Antigens of the major histocompatibility system in ischemic heart disease and idiopathic dilated cardiomyopathy |
Q71788167 | Association between Antibodies to the MR 67,000 Isoform of Glutamate Decarboxylase (GAD) and Type 1 (Insulin-Dependent) Diabetes Mellitus with Coexisting Autoimmune Polyendocrine Syndrome Type II |
Q34715410 | Autoantibodies in autoimmune polyendocrine syndrome type II. |
Q34394963 | Autoimmune enteropathy and colitis: is there a generalised autoimmune gut disorder? |
Q58054593 | Autoimmune enteropathy and villous atrophy in adults |
Q34955595 | Autoimmune enteropathy in children and adults. |
Q68136817 | Autoimmune liver diseases |
Q73173850 | Autoimmunity as a special case of immunity: removing threats from within |
Q36708258 | Autoimmunity to glutamic acid decarboxylase (GAD) in stiffman syndrome and insulin-dependent diabetes mellitus |
Q37726181 | Autologous CD4 T-cell responses to ectopic class II major histocompatibility complex antigen-expressing single-cell islet cells: an in vitro insight into the pathogenesis of lymphocytic insulitis in nonobese diabetic mice |
Q40654813 | B-cell factor 1 is required for optimal expression of the DRA promoter in B cells |
Q36839586 | Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression |
Q36363437 | Characterization of a cis-acting regulatory element which silences expression of the class II-A beta gene in epithelium |
Q52060730 | Circulating cytotoxic immune components in dominant Charcot-Marie-Tooth syndrome. |
Q68768012 | Circulating thyroid and gastric parietal cell autoantibodies in patients with multiple sclerosis |
Q49043612 | Class II MHC antigens in vivo induced by the diabetogen streptozotocin in BALB/c mice |
Q37051232 | Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy |
Q73190472 | Clinical manifestations of IgE hypogammaglobulinemia |
Q33867492 | Cloning of the major histocompatibility complex class II promoter binding protein affected in a hereditary defect in class II gene regulation |
Q41152645 | Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies |
Q71914703 | Comparative immunocytochemical study of MHC class II expression in human donor pancreas and isolated islets |
Q43434628 | Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. |
Q33814684 | Determinants of the B-cell response against a transgenic autoantigen |
Q42512857 | Differential expression and regulation of major histocompatibility complex (MHC) products in neural and glial cells of the human fetal brain |
Q45179911 | Divergent effects of thyroid HLA-antigens on T and natural killer (NK) cell cytotoxicity |
Q35179369 | Duke-Elder Lecture: new concepts on the role of autoimmunity in the pathogenesis of uveitis |
Q41355359 | Effects of Tumor Necrosis Factor-α, Interleukin-1β, and Interleukin-6 on Type I Iodothyronine 5′-Deiodination in Rat Thyroid Cell Line, FRTL-5 |
Q69809125 | Enhancement of thyrocyte HLA class II expression by thyroid stimulating hormone |
Q38219241 | Etiologic factors and pathogenetic aspects of organ-specific autoimmune diseases. Essential role of autoreactive T cells and lymphokine network in the activation of effector systems responsible for tissue lesions |
Q41431603 | Ets-1 activates the DRA promoter in B cells |
Q24562002 | Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y |
Q41703222 | Gamma-interferon induces differential expression of HLA-DR, -DP and -DQ in human ciliary epithelial cells |
Q74626125 | Gene therapy of primary immunodeficiencies |
Q57281203 | Glial cells as suppressor cells: Characterization of the inhibitory function |
Q34016626 | HLA antigens in idiopathic dilated cardiomyopathy |
Q70362833 | HLA-D subregion expression by thyroid epithelium in autoimmune thyroid diseases and induced in vitro |
Q70049441 | HgC12 induces T and B cells to proliferate and differentiate in BN rats |
Q38028575 | Hormonal support of lacrimal function, primary lacrimal deficiency, autoimmunity, and peripheral tolerance in the lacrimal gland |
Q24318380 | Human X-box-binding protein 1 is required for the transcription of a subset of human class II major histocompatibility genes and forms a heterodimer with c-fos |
Q38142280 | I-E transgenic mice: a model system to dissect the regulation and function of MHC class II genes in vivo |
Q47712238 | IL-10 expression in thyroid glands: protective or harmful role against thyroid autoimmunity? |
Q41423569 | Immune mechanisms in autoimmune ocular disease |
Q32100459 | Immune regulation of ovarian function in buffaloes (Bubalus bubalus). |
Q48131721 | Immune response to specific molecules of the retina in proliferative vitreoretinal disorders |
Q39574530 | Immunochemical and molecular properties of antibodies exhibiting binding properties to glutamic acid-tyrosine homopolymer and to self antigens |
Q38016619 | Immunogenetic mechanisms in myasthenia gravis. |
Q43939897 | In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse |
Q42160051 | In vivo modulation of CD1 and MHC class II expression by sheep afferent lymph dendritic cells. Comparison of primary and secondary immune responses |
Q36353914 | In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon |
Q67681089 | Increased CD5-positive B lymphocytes in type I diabetes |
Q70692624 | Increased epithelial expression of HLA-DQ and HLA-DP molecules in salivary glands from patients with Sjögren's syndrome compared with obstructive sialadenitis |
Q69744083 | Increased expression of class II antigens of the major histocompatibility complex on alveolar macrophages and alveolar type II cells and interleukin-1 (IL-1) secretion from alveolar macrophages in an animal model of silicosis |
Q71736162 | Increased frequency of organ-specific cardiac antibodies in healthy relatives of patients with dilated cardiomyopathy: evidence for autoimmunity in Polish families |
Q42774282 | Induction of HLA-DR expression on human myoblasts with interferon-gamma |
Q68372148 | Induction of MHC class II antigen in cultured bovine ciliary epithelial cells |
Q37299707 | Insulin dependent diabetes mellitus susceptibility or protection may be determined by certain HLA-DQ molecules |
Q28326428 | Interferon gamma-mediated renal MHC expression in mercuric chloride-induced glomerulonephritis |
Q72664942 | Is immunologic tolerance of self modulated through antigen presentation by parenchymal epithelium? |
Q57449558 | Islet Cell Surface Antibodies Are More Common in Patients and Relatives in Areas and during Seasons with High Incidence of Insulin-Dependent Diabetes Mellitus |
Q43701540 | LFA-1 and ICAM-1 molecule expression in jejunal mucosa from children with autoimmune enteropathy |
Q44519201 | Lack of 64,000-M(r) islet autoantigen overexpression and antibody development following coxsackievirus B4 infection in diabetes-resistant mice |
Q70059781 | Lymphocytic infiltration and HLA-DR expression of salivary glands in bone marrow transplant recipients: a prospective study |
Q40505332 | MHC class II gene expression is not induced in HPIV3-infected respiratory epithelial cells |
Q41134326 | Major histocompatibility complex class II deficiency: a disease of gene regulation. |
Q38342198 | Mutational analysis of the DRA promoter: cis-acting sequences and trans-acting factors |
Q42468666 | Non-polarized cell surface expression of HLA-A,B,C and HLA-DR antigens in Graves' thyroid follicle cells. |
Q37421850 | Novel considerations on the antibody/autoantigen system in type I (insulin-dependent) diabetes mellitus |
Q42464392 | Organ-specific cardiac antibodies: serological markers for systemic hypertension in autoimmune polyendocrinopathy |
Q24315739 | RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency |
Q34275894 | Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes |
Q37946773 | Regulation of the local immune response by retinal cells |
Q69369629 | Retrovirus-like sequences in Graves' disease: implications for human autoimmunity |
Q33614482 | Role of autoimmunity in dilated cardiomyopathy |
Q36369564 | Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene. |
Q46127712 | Specific hla-dqa and hla-drb1 alleles confer susceptibility to sjögren's syndrome and autoantibody production |
Q43717779 | T cell recognition of epithelial self |
Q41885582 | T cell-dependent class II major histocompatibility complex antigen expression in vivo induced by the diabetogen streptozotocin. |
Q42166847 | The Idd6.2 diabetes susceptibility region controls defective expression of the Lrmp gene in nonobese diabetic (NOD) mice |
Q35016153 | The MHC class II E beta promoter: a complex arrangement of positive and negative elements determines B cell and interferon-gamma (IFN-gamma) regulated expression |
Q41681004 | The Neuronal Toxic Factor in Serum of Type 1 Diabetic Patients is a Complement‐fixing Autoantibody |
Q59021440 | The case of the wonky mouse |
Q73480806 | The distribution and abundance of MHC and ICAM-1 on Schwann cells in vitro |
Q43456236 | The expression and regulation of class II antigens in normal and inflammatory bowel disease peripheral blood monocytes and intestinal epithelium |
Q33842970 | The human leukocyte antigen complex and chronic ocular inflammatory disorders |
Q33805252 | The molecular basis of MHC class II deficiency and transcriptional control of MHC class II gene expression. |
Q36834902 | The progression of renal diseases: On the pathogenesis of renal interstitial fibrosis |
Q33927166 | The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity |
Q67742286 | The role of interferon-gamma in lymphocytic thyroiditis: its functional and pathological effect on human thyrocytes in culture |
Q43577080 | Thyroid autoimmunity in endemic goitre caused by excessive iodine intake |
Q45148526 | Tolerance in Transgenic Mice Expressing Major Histocompatibility Molecules Extrathymically on Pancreatic Cells |
Q37827090 | Transcriptional regulation of HLA class-II genes |
Q36839439 | Transcriptional regulation of HLA-DRA gene |
Q37835886 | Transfection of genes for cell surface products involved in antigen presentation--applications to the understanding of autoimmunity |
Q36720139 | Two DNA-binding proteins discriminate between the promoters of different members of the major histocompatibility complex class II multigene family |
Q34187742 | Unlike thyrotropin, thyroid-stimulating antibodies do not activate phospholipase C in human thyroid slices |
Q46860879 | Unresponsiveness to a foreign antigen can be caused by self-tolerance |
Search more.